BELOW:
- AGENDA OF MEETING WITH SPEAKERS, TOPICS (PDF)
- FDA'S BRIEFING DOCUMENT (PDF)
- PFIZER BRIEFING DOCUMENT (PDF)
NEW YORK (WBEN) -- The Center for Biologics Evaluation and Research's Vaccines and Related Biological Products Advisory Committee (VRBPAC) -- which advises the FDA -- will meet Thursday in open session (WATCH LIVE AT 9 A.M. ABOVE) to discuss emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine in individuals 16 years of age and older and advise whether to approve it or not.
The regulators and medial experts will kick off their day of sessions at 9 a.m., and adjourn at 5:15 p.m. -- with a recommendation in hand. (SEE DOCUMENTS BELOW)
Pfizer-Biontech COVID-19 vaccine briefing document by David Caplan on Scribd
